Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Acta Oncologica (Stockholm, Sweden)|February 24, 2023
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancerMichael C Repka, Michael Carrasquilla, Ima Paydar, et al.
Cureus|February 25, 2025
Timing and Patterns of Potentially Salvageable Recurrences Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer Assessed by Preferential Amino Acid UptakeTim Kearney, Lauren Nagel, Matthew Bourne, et al.
Frontiers in Oncology|June 28, 2024
Comparative analysis of plan quality and delivery efficiency: ZAP-X vs. CyberKnife for brain metastases treatmentYing Niu, Abdul Rashid, Jui-Min Lee, et al.
Frontiers in Oncology|January 31, 2022
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint TherapyAidan M Burke, Michael Carrasquilla, Walter C Jean, et al.
Advances in Radiation Oncology|December 29, 2022
High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and ImmunotherapyMichael Carrasquilla, Nitika Paudel, Brian T Collins, et al.
Cureus|July 14, 2025
Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer: The Georgetown University ExperienceVaibhav Sharma, Tim Kearney, Zach Lee, et al.
Frontiers in Oncology|March 15, 2021
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate CancerNima Aghdam, Michael Carrasquilla, Edina Wang, et al.
Frontiers in Oncology|February 11, 2020
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)Nima Aghdam, Abigail Pepin, Michael Carrasquilla, et al.
Frontiers in Oncology|November 1, 2024
Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancerMin Ji Koh, Padraig Pilkington, Min Jung Koh, et al.
Frontiers in Oncology|February 3, 2025
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapyMin Jung Koh, Min Ji Koh, Jessica Y Hsueh, et al.
Pageof 2